Talha Badar: Evidence-Based Clinical Algorithm for Newly Diagnosed Ph+ ALL
Talha Badar/X

Talha Badar: Evidence-Based Clinical Algorithm for Newly Diagnosed Ph+ ALL

Talha Badar, Associate Professor of Medicine at Mayo Clinic, shared on X:

“New on Open Medicine Insights. On call and need a quick refresher on newly diagnosed Ph+ ALL?

I created a practical, evidence-based clinical algorithm covering:

  •  Frontline TKI selection
  •  Early blinatumomab integration
  •  MRD-guided decision making
  •  When to consider allo-HCT

Ideal for fellows on call or anyone looking for a rapid review of modern Ph_pos, ALL management.”

Read here.

You might be interested in:

AIEOP-BFM ALL 2017: Blinatumomab Successfully Replaces Two Intensive Chemotherapy Blocks in High-Risk Pediatric B-ALL

Talha Badar: Evidence-Based Clinical Algorithm for Newly Diagnosed Ph+ ALL